EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

The global, prospective, non-randomized UNTOUCHED study evaluated the safety and efficacy of the Boston Scientific Emblem S-ICD System – the only approved implantable defibrillator without wires touching the heart – for primary prevention of sudden cardiac death specifically in patients with a left ventricular ejection fraction (LVEF) ≤35 percent, the most common population to be indicated for ICD therapy. #Heartrhythm2020 #HRS20 #HRS2020
News | Implantable Cardioverter Defibrillator (ICD)
UNTOUCHED Trial Data Underscores Safety And Efficacy Of Boston Scientific S-ICD System

May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) System ...

Home May 08, 2020
Home
The Swiss-AF study shows High Incidence Of Silent Brain Infarcts Found in Anticoagulated Atrial Fibrillation Patients. #Heartrhythm2020 #HRS20 #HRS2020
News | Atrial Fibrillation
High Incidence Of Silent Brain Infarcts Found in Anticoagulated Atrial Fibrillation Patients

May 8, 2020 – A new clinical study found that patients with atrial fibrillation (AF) experienced a high incidence of ...

Home May 08, 2020
Home
PINNACLE FLX Study of New Watchman FLX LAA Occluder Meets Safety and Efficacy Endpoints. #Heartrhythm2020 #HRS20 #HRS2020
News | Atrial Fibrillation
PINNACLE FLX Study of New Watchman FLX LAA Occluder Meets Safety and Efficacy Endpoints 

May 8, 2020 — Positive 12-month results were announced today from the PINNACLE FLX clinical trial assessing the safety ...

Home May 08, 2020
Home
The SERF VT EFS is a groundbreaking, single-arm observational study designed to evaluate the safety and effectiveness of the Thermedical Durablate catheter to treat VT. #HRS20 #HRS2020 #heartrhythm2020
News
Saline Enhanced Radiofrequency Ablation May be an Effective Method to Treat Ventricular Tachycardia

May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SERF) ...

Home May 08, 2020
Home
The first-in-human results show positive results for Medtronic's pulsed field ablation in safety and efficiency. #Heartrhythm2020 #HRS2020 #HRS20
News | Atrial Fibrillation
Pulsed AF Trial Shows Pulsed Field Ablation May be Safer Than Traditional RF Ablations

May 8, 2020 — New clinical trial reveals the first-in-human results for paroxysmal or persistent atrial fibrillation (AF ...

Home May 08, 2020
Home
The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.
Feature | Implantable Cardioverter Defibrillator (ICD)
Head-to-head Comparison Shows Subcutaneous ICDs Safer Than Transvenous Defibrillators 

May 8, 2020 — A new clinical trial is the first to compare the safety and efficacy of subcutaneous implantable ...

Home May 08, 2020
Home
The Affera Inc. pulsed field (PF) energy radiofrequency ablation system. First-in-human trial shows new point-by-point approach provides increased flexibility and efficiency for physicians treating arrhythmia patients. #HRS #HRS2020 #HRS20 #heartrhythm20
Feature
Pulsed Field Ablation Successfully Treats Atrial Fibrillation

May 8, 2020 — A new clinical trial effectively uses pulsed field (PF) energy to treat patients with persistent or ...

Home May 08, 2020
Home
Necklace Patient Monitor Detects Abnormal Heart Rhythm. An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on EHRA Essentials 4 You, a scientific platform of the European Society of Cardiology (ESC). This wearable necklace ECG monitor provides a new and easy method for detecting an abnormal heart rhythm called atrial fibrillation and is accurate, according to a new study from the University of Eastern Finland.
News | Wearables
Necklace Monitors ECG and Detects Abnormal Heart Rhythms

May 2020 — An necklace has been developed that detects abnormal heart rhythm will be showcased for the first time on EHR ...

Home May 08, 2020
Home
Cardiac Insight's Heart@Home ECG Test Kit can help address new telehealth demands placed on cardiology practices by the COVID-19 response using arrhythmia diagnosis technology of the wearable Cardea Solo Sensor.
News | ECG Wireless Remote Access
Cardiac Insight Launches New Telehealth Solution for Cardiology Practices with Heart@Home ECG Test Kit

May 4, 2020 — Cardiac Insight Inc., a U.S.-based digital healthcare innovator specializing in body-worn sensor ...

Home May 04, 2020
Home
EP lab photo from Philips Healthcare
News | EP Lab
HRS Addresses EP Fellow Issues During Pandemic

May 1, 2020 — The Heart Rhythm Society (HRS) has created a COVID-19 Task Force to make recommendations related to ...

Home April 30, 2020
Home
There have been several safety reports to the FDA that COVID-19 patients receiving hydroxychloroquine and chloroquine, either aloneaths and Injuries From Use of Antimalarial Drugs in COVID-19 Patients. he U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication today reminding doctors there are serious side effects when using hydroxychloroquine and chloroquine in the off-lable use to treat COVID-19 patients. This includes potentially life-threatening heart rhythms. #COVID19 #SARScov2
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor
FDA Reports of Deaths and Injuries From Use of Antimalarial hydroxychloroquine in COVID-19 Patients

April 23, 2020 — The U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication today reminding doctors ...

Home April 24, 2020
Home
Caution Recommended in use of COVID-19 Therapy Using Hydroxychloroquine and Azithromycin in Cardiovascular Disease Patients
Feature | Coronavirus (COVID-19)
AHA, ACC, HRS Caution Use of COVID-19 Therapies Hydroxychloroquine and Azithromycin in Cardiac Patients

April 8, 2020 – The scientific community is learning more about the impact and interaction of cardiovascular diseases ...

Home April 08, 2020
Home
While the HRS annual meeting is cancelled, the society has created a resource page to help its members in the fight against COVID-19 at https://www.hrsonline.org/COVID19-Challenges-Solutions. #HRS #COVID19 #coronavirus #SARScov2
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor
Heart Rhythm Society Cancels 2020 Meeting Due to COVID-19

April 1, 2020 — Due to the continued global escalation of the novel coronavirus (COVID-19, SARS-CoV-2), the Heart Rhythm ...

Home April 01, 2020
Home
POPULAR TAVR trial Shows Oral Anticoagulants Alone in atrial fibrillation (AF) Patients Reduces Bleeding Post TAVR, transcatheter aortic valve replacement. #ACC20 #ACC2020
News | Atrial Fibrillation
POPULAR TAVR Shows Oral Anticoagulants Alone in AF Patients Reduces Bleeding Post TAVR

March 29, 2020 — Patients with atrial fibrillation (AF) who took oral anticoagulants alone after undergoing ...

Home March 29, 2020
Home
Hydroxychloroquine causes prolonged QT intervals and cardiac arrhythmias, so this needs to be considered in patients being treated with this drug for COVID-19. #COVID19 #SARScov2 #coronavirus
Feature | Coronavirus (COVID-19) | Marianne Pop, Pharm.D, BCPS
COVID-19 Hydroxychloroquine Treatment Brings Prolonged QT Arrhythmia Issues

It has been more than three months since the word coronavirus was uttered on everyone’s lips and all over the social ...

Home March 24, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now